STOCK TITAN

[Form 4] Terns Pharmaceuticals, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

Hewlett Packard Enterprise (HPE) Form 4 filing, dated 06/30/2025, discloses an insider sale by Jeremy K. Cox, Senior Vice President, Controller & CTO. On 06/27/2025 Mr. Cox sold 68,590 shares of HPE common stock at a weighted-average price of $18.4374 (price range: $18.425-$18.440). Following the transaction, his reported direct ownership fell to 0 shares, indicating a complete disposition of his directly held stock. The transaction was coded “S,” denoting an open-market sale; the filing does not state that it was executed under a Rule 10b5-1 trading plan. No derivative securities were reported.

While the volume sold is modest relative to HPE’s average daily trading volume, the full liquidation of the officer’s position may be viewed by some investors as a potential negative signal regarding near-term share performance or personal liquidity preferences. The filing contains no financial results or strategic details and therefore has low direct fundamental impact on HPE’s operations, but it provides timely governance and sentiment information relevant to shareholder monitoring of insider activity.

Il deposito Form 4 di Hewlett Packard Enterprise (HPE), datato 30/06/2025, rivela una vendita da parte dell'insider Jeremy K. Cox, Senior Vice President, Controller e CTO. Il 27/06/2025 il Sig. Cox ha venduto 68.590 azioni ordinarie HPE a un prezzo medio ponderato di 18,4374 $ (intervallo di prezzo: 18,425-18,440 $). Dopo la transazione, la sua proprietà diretta segnalata è scesa a 0 azioni, indicando una completa cessione delle azioni detenute direttamente. L’operazione è stata classificata come “S”, ovvero vendita sul mercato aperto; il deposito non specifica che sia stata eseguita nell’ambito di un piano di negoziazione Rule 10b5-1. Non sono stati segnalati strumenti derivati.

Nonostante il volume venduto sia modesto rispetto al volume medio giornaliero di HPE, la liquidazione totale della posizione dell’ufficiale potrebbe essere interpretata da alcuni investitori come un segnale negativo potenziale riguardo alla performance azionaria a breve termine o alle preferenze di liquidità personali. Il deposito non contiene risultati finanziari o dettagli strategici e pertanto ha un impatto fondamentale diretto basso sulle operazioni di HPE, ma fornisce informazioni tempestive su governance e sentiment utili al monitoraggio delle attività degli insider da parte degli azionisti.

La presentación del Formulario 4 de Hewlett Packard Enterprise (HPE), fechada el 30/06/2025, revela una venta por parte del insider Jeremy K. Cox, Vicepresidente Senior, Controller y CTO. El 27/06/2025, el Sr. Cox vendió 68,590 acciones ordinarias de HPE a un precio promedio ponderado de 18.4374 $ (rango de precio: 18.425-18.440 $). Tras la transacción, su propiedad directa reportada cayó a 0 acciones, indicando una disposición completa de sus acciones directamente poseídas. La operación fue codificada como “S”, denotando una venta en el mercado abierto; la presentación no indica que se haya ejecutado bajo un plan de negociación Rule 10b5-1. No se reportaron valores derivados.

Aunque el volumen vendido es modesto en relación con el volumen diario promedio de HPE, la liquidación total de la posición del ejecutivo puede ser vista por algunos inversores como una señal potencial negativa respecto al desempeño de las acciones a corto plazo o a preferencias personales de liquidez. La presentación no contiene resultados financieros ni detalles estratégicos, por lo que tiene un bajo impacto fundamental directo en las operaciones de HPE, pero proporciona información oportuna sobre gobernanza y sentimiento relevante para el monitoreo de la actividad de los insiders por parte de los accionistas.

Hewlett Packard Enterprise(HPE)의 2025년 6월 30일자 Form 4 제출서류는 수석 부사장 겸 컨트롤러 및 CTO인 Jeremy K. Cox의 내부자 주식 매도를 공개합니다. 2025년 6월 27일, Cox 씨는 HPE 보통주 68,590주를 가중평균 가격 18.4374달러(가격 범위: 18.425~18.440달러)에 매도했습니다. 거래 후 그의 직접 보유 주식 수는 0주로 보고되어, 직접 보유 주식을 전량 처분했음을 나타냅니다. 거래는 “S” 코드로 표시되어 공개 시장 매도임을 나타내며, Rule 10b5-1 거래 계획에 따른 실행 여부는 명시되어 있지 않습니다. 파생 증권은 보고되지 않았습니다.

매도량은 HPE의 일평균 거래량에 비해 적은 편이지만, 임원의 보유 주식 전량 매도는 일부 투자자들에게 단기 주가 성과나 개인 유동성 선호도에 대한 부정적 신호로 해석될 수 있습니다. 제출서류에는 재무 실적이나 전략적 세부사항이 포함되어 있지 않아 HPE 운영에 대한 직접적인 기본적 영향은 낮지만, 주주들이 내부자 활동을 모니터링하는 데 유용한 시기적절한 거버넌스 및 투자자 심리 정보를 제공합니다.

Le dépôt du Formulaire 4 de Hewlett Packard Enterprise (HPE), daté du 30/06/2025, révèle une vente d'initié par Jeremy K. Cox, Vice-Président Senior, Contrôleur et CTO. Le 27/06/2025, M. Cox a vendu 68 590 actions ordinaires HPE à un prix moyen pondéré de 18,4374 $ (fourchette de prix : 18,425-18,440 $). Suite à cette transaction, sa détention directe déclarée est tombée à 0 action, indiquant une cession complète de ses actions détenues directement. La transaction a été codée « S », signifiant une vente sur le marché ouvert ; le dépôt ne précise pas qu’elle a été réalisée dans le cadre d’un plan de trading Rule 10b5-1. Aucun titre dérivé n’a été signalé.

Bien que le volume vendu soit modeste par rapport au volume moyen quotidien de HPE, la liquidation totale de la position de l’officier peut être perçue par certains investisseurs comme un signal potentiellement négatif concernant la performance à court terme de l’action ou les préférences personnelles de liquidité. Le dépôt ne contient aucun résultat financier ni détail stratégique et a donc un faible impact fondamental direct sur les opérations de HPE, mais il fournit des informations opportunes sur la gouvernance et le sentiment, pertinentes pour la surveillance par les actionnaires des activités des initiés.

Die Form 4 Einreichung von Hewlett Packard Enterprise (HPE) vom 30.06.2025 offenbart einen Insider-Verkauf durch Jeremy K. Cox, Senior Vice President, Controller & CTO. Am 27.06.2025 verkaufte Herr Cox 68.590 Aktien der HPE-Stammaktien zu einem gewichteten Durchschnittspreis von 18,4374 $ (Preisspanne: 18,425-18,440 $). Nach der Transaktion fiel sein gemeldeter Direktbesitz auf 0 Aktien, was auf eine vollständige Veräußerung seiner direkt gehaltenen Aktien hinweist. Die Transaktion wurde mit „S“ codiert, was einen Verkauf am offenen Markt bedeutet; die Einreichung gibt nicht an, dass die Ausführung unter einem Rule 10b5-1 Handelsplan erfolgte. Es wurden keine derivativen Wertpapiere gemeldet.

Obwohl das verkaufte Volumen im Vergleich zum durchschnittlichen Tagesvolumen von HPE gering ist, könnte die vollständige Liquidation der Position des Offiziers von einigen Investoren als potenziell negatives Signal für die kurzfristige Kursentwicklung oder persönliche Liquiditätspräferenzen angesehen werden. Die Einreichung enthält keine finanziellen Ergebnisse oder strategischen Details und hat daher einen geringen direkten fundamentalen Einfluss auf die Geschäftstätigkeit von HPE, liefert jedoch zeitnahe Governance- und Stimmungsinformationen, die für die Überwachung von Insider-Aktivitäten durch Aktionäre relevant sind.

Positive
  • None.
Negative
  • Senior officer sold 68,590 shares, reducing direct ownership to zero, which can be interpreted as a bearish insider sentiment signal.

Insights

TL;DR: Senior officer liquidated entire direct HPE stake; sentiment-negative, limited fundamental impact.

Jeremy K. Cox’s sale of 68,590 shares, leaving him with zero directly held shares, eliminates the alignment incentive tied to personal equity exposure. Although the dollar value (~$1.26 million) is immaterial to HPE’s market cap, full disposals by C-suite members typically attract governance scrutiny. Absence of a disclosed Rule 10b5-1 plan suggests discretionary timing. However, HPE’s broad institutional ownership and liquidity mean this sale alone is unlikely to influence price materially. Investors should view the action as a modest sentiment headwind rather than a signal of underlying operational weakness.

Il deposito Form 4 di Hewlett Packard Enterprise (HPE), datato 30/06/2025, rivela una vendita da parte dell'insider Jeremy K. Cox, Senior Vice President, Controller e CTO. Il 27/06/2025 il Sig. Cox ha venduto 68.590 azioni ordinarie HPE a un prezzo medio ponderato di 18,4374 $ (intervallo di prezzo: 18,425-18,440 $). Dopo la transazione, la sua proprietà diretta segnalata è scesa a 0 azioni, indicando una completa cessione delle azioni detenute direttamente. L’operazione è stata classificata come “S”, ovvero vendita sul mercato aperto; il deposito non specifica che sia stata eseguita nell’ambito di un piano di negoziazione Rule 10b5-1. Non sono stati segnalati strumenti derivati.

Nonostante il volume venduto sia modesto rispetto al volume medio giornaliero di HPE, la liquidazione totale della posizione dell’ufficiale potrebbe essere interpretata da alcuni investitori come un segnale negativo potenziale riguardo alla performance azionaria a breve termine o alle preferenze di liquidità personali. Il deposito non contiene risultati finanziari o dettagli strategici e pertanto ha un impatto fondamentale diretto basso sulle operazioni di HPE, ma fornisce informazioni tempestive su governance e sentiment utili al monitoraggio delle attività degli insider da parte degli azionisti.

La presentación del Formulario 4 de Hewlett Packard Enterprise (HPE), fechada el 30/06/2025, revela una venta por parte del insider Jeremy K. Cox, Vicepresidente Senior, Controller y CTO. El 27/06/2025, el Sr. Cox vendió 68,590 acciones ordinarias de HPE a un precio promedio ponderado de 18.4374 $ (rango de precio: 18.425-18.440 $). Tras la transacción, su propiedad directa reportada cayó a 0 acciones, indicando una disposición completa de sus acciones directamente poseídas. La operación fue codificada como “S”, denotando una venta en el mercado abierto; la presentación no indica que se haya ejecutado bajo un plan de negociación Rule 10b5-1. No se reportaron valores derivados.

Aunque el volumen vendido es modesto en relación con el volumen diario promedio de HPE, la liquidación total de la posición del ejecutivo puede ser vista por algunos inversores como una señal potencial negativa respecto al desempeño de las acciones a corto plazo o a preferencias personales de liquidez. La presentación no contiene resultados financieros ni detalles estratégicos, por lo que tiene un bajo impacto fundamental directo en las operaciones de HPE, pero proporciona información oportuna sobre gobernanza y sentimiento relevante para el monitoreo de la actividad de los insiders por parte de los accionistas.

Hewlett Packard Enterprise(HPE)의 2025년 6월 30일자 Form 4 제출서류는 수석 부사장 겸 컨트롤러 및 CTO인 Jeremy K. Cox의 내부자 주식 매도를 공개합니다. 2025년 6월 27일, Cox 씨는 HPE 보통주 68,590주를 가중평균 가격 18.4374달러(가격 범위: 18.425~18.440달러)에 매도했습니다. 거래 후 그의 직접 보유 주식 수는 0주로 보고되어, 직접 보유 주식을 전량 처분했음을 나타냅니다. 거래는 “S” 코드로 표시되어 공개 시장 매도임을 나타내며, Rule 10b5-1 거래 계획에 따른 실행 여부는 명시되어 있지 않습니다. 파생 증권은 보고되지 않았습니다.

매도량은 HPE의 일평균 거래량에 비해 적은 편이지만, 임원의 보유 주식 전량 매도는 일부 투자자들에게 단기 주가 성과나 개인 유동성 선호도에 대한 부정적 신호로 해석될 수 있습니다. 제출서류에는 재무 실적이나 전략적 세부사항이 포함되어 있지 않아 HPE 운영에 대한 직접적인 기본적 영향은 낮지만, 주주들이 내부자 활동을 모니터링하는 데 유용한 시기적절한 거버넌스 및 투자자 심리 정보를 제공합니다.

Le dépôt du Formulaire 4 de Hewlett Packard Enterprise (HPE), daté du 30/06/2025, révèle une vente d'initié par Jeremy K. Cox, Vice-Président Senior, Contrôleur et CTO. Le 27/06/2025, M. Cox a vendu 68 590 actions ordinaires HPE à un prix moyen pondéré de 18,4374 $ (fourchette de prix : 18,425-18,440 $). Suite à cette transaction, sa détention directe déclarée est tombée à 0 action, indiquant une cession complète de ses actions détenues directement. La transaction a été codée « S », signifiant une vente sur le marché ouvert ; le dépôt ne précise pas qu’elle a été réalisée dans le cadre d’un plan de trading Rule 10b5-1. Aucun titre dérivé n’a été signalé.

Bien que le volume vendu soit modeste par rapport au volume moyen quotidien de HPE, la liquidation totale de la position de l’officier peut être perçue par certains investisseurs comme un signal potentiellement négatif concernant la performance à court terme de l’action ou les préférences personnelles de liquidité. Le dépôt ne contient aucun résultat financier ni détail stratégique et a donc un faible impact fondamental direct sur les opérations de HPE, mais il fournit des informations opportunes sur la gouvernance et le sentiment, pertinentes pour la surveillance par les actionnaires des activités des initiés.

Die Form 4 Einreichung von Hewlett Packard Enterprise (HPE) vom 30.06.2025 offenbart einen Insider-Verkauf durch Jeremy K. Cox, Senior Vice President, Controller & CTO. Am 27.06.2025 verkaufte Herr Cox 68.590 Aktien der HPE-Stammaktien zu einem gewichteten Durchschnittspreis von 18,4374 $ (Preisspanne: 18,425-18,440 $). Nach der Transaktion fiel sein gemeldeter Direktbesitz auf 0 Aktien, was auf eine vollständige Veräußerung seiner direkt gehaltenen Aktien hinweist. Die Transaktion wurde mit „S“ codiert, was einen Verkauf am offenen Markt bedeutet; die Einreichung gibt nicht an, dass die Ausführung unter einem Rule 10b5-1 Handelsplan erfolgte. Es wurden keine derivativen Wertpapiere gemeldet.

Obwohl das verkaufte Volumen im Vergleich zum durchschnittlichen Tagesvolumen von HPE gering ist, könnte die vollständige Liquidation der Position des Offiziers von einigen Investoren als potenziell negatives Signal für die kurzfristige Kursentwicklung oder persönliche Liquiditätspräferenzen angesehen werden. Die Einreichung enthält keine finanziellen Ergebnisse oder strategischen Details und hat daher einen geringen direkten fundamentalen Einfluss auf die Geschäftstätigkeit von HPE, liefert jedoch zeitnahe Governance- und Stimmungsinformationen, die für die Überwachung von Insider-Aktivitäten durch Aktionäre relevant sind.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gengos Andrew

(Last) (First) (Middle)
C/O TERNS PHARMACEUTICALS, INC.
1065 EAST HILLSDALE BLVD., SUITE 100

(Street)
FOSTER CITY CA 94404

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Terns Pharmaceuticals, Inc. [ TERN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
06/27/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/27/2025 P 5,000 A $3.9267 20,000 D
Common Stock 06/27/2025 P 5,000 A $3.9299 25,000 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
/s/ David Strauss, as Attorney-in-Fact for Andrew Gengos 06/30/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many HPE shares did Jeremy K. Cox sell?

He sold 68,590 shares of Hewlett Packard Enterprise common stock.

At what price were the HPE shares sold?

The weighted-average sale price was $18.4374 per share, with individual trades ranging from $18.425 to $18.440.

Does Jeremy K. Cox still own HPE shares after the sale?

According to the Form 4, his direct ownership is now 0 shares.

Was the HPE insider sale made under a Rule 10b5-1 trading plan?

The filing does not indicate that the transaction was executed under a Rule 10b5-1 plan.

Why is insider selling important to HPE investors?

Large or complete disposals by senior executives can signal perceived overvaluation or personal liquidity needs, influencing investor sentiment toward HPE.
Terns Pharmaceuticals, Inc.

NASDAQ:TERN

TERN Rankings

TERN Latest News

TERN Latest SEC Filings

TERN Stock Data

349.35M
79.51M
0.26%
108.17%
7.29%
Biotechnology
Pharmaceutical Preparations
Link
United States
FOSTER CITY